According to the research report titled  ‘Asia Pacific Apheresis Equipment Market Share By Product, Application,A Procedure, Technology, Industry Analysis Report, Regional Outlook, Application Potential, Competitive Market Share & Forecast, 2020 – 2026’, available with Market Study Report, Asia-Pacific apheresis equipment market is expected to cross USD 1.3 billion by the year 2026.
 

Increased pervasiveness of blood disorders has impelled the demand for apheresis equipment, which in turn is a major factor driving the market growth in Asia-Pacific. For those uninitiated, apheresis is a blood processing technique which is used for treating clinical conditions such as neurologic, neoplastic and hematologic disorders. Apheresis equipment can also help in lowering the number of pathogens in plasma and in platelets, thereby stimulating the industry outlook.
 

Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/2683090/
 

Focus towards development of healthcare infrastructure is further aiding the market expansion. Additionally, introduction of blood safety strategies by public entities towards providing adequate and safe blood supply is facilitating the business scenario in Asia-Pacific.
 

Rising number of accredited and licensed blood banks are also augmenting the industry remuneration. However, high capital investments associated with apheresis techniques may act as a restraining factor to the overall market growth.
 

As per product type, the report claims that apheresis machine segment accounted for substantial revenue share in the year 2019 and is expected to grow with a CAGR of 15% through 2026. These machines are used to obtain blood from donors and subsequently separate it into various blood components including red blood cells, white blood cells, platelets and plasma. Ongoing advancements in apheresis machines is thus fueling the segmental share.
 

Elaborating on the application spectrum, Asia-Pacific apheresis equipment market from hematology segment generated revenues worth USD 225 million in the year 2019. HAU (Hematology apheresis unit) is widely used to analyze blood and marrow components. In addition, growing demand for blood and blood products is favoring the overall market outlook in APAC.
 

Moving on to procedure type, the report claims that leukapheresis segment is predicted to reach a valuation of USD 110 million by the year 2026. This procedure helps in removing additional leukocytes from the blood. Rising prevalence of febrile neutropenia is positively influencing the growth of the segment.
 

In terms of technology, membrane filtration segment was worth USD 405.5 million in the year 2019. Rising adoption of membrane filtration technology owing to its high precision and cost effective nature is favoring the market scenario in Asia-Pacific.
 

Regionally, India apheresis equipment market is anticipated to showcase a y-o-y growth rate of 12.8% between 2020 and 2026. Technological advancements and increasing investments towards healthcare sector are augmenting the regional demand for apheresis equipment.
 

Therakos Inc., Terumo BCT Inc., Kawasumi Laboratories Inc., Haemonetics Corporation, Fresenius SE & Co. KGaA, Kaneka Corporation, B. Braun Melsungen AG, and Asahi Kasei Corporation are the key participants in Asia-Pacific apheresis equipment market.